Search Reports


Chemicals and Materials » Materials »

Human Microbiome Market, Size, Share, Outlook and Growth Opportunities 2020-2026

  • ID:OGA1910MVHC5894
  • Published: October-2019
  • Pages:110
  • OG Analysis
1 of 3

Global Human Microbiome Market, Size, Share, Outlook and Growth Opportunities to 2026: By Product (Prebiotics, Probiotics, Medical Foods, Foods, Drugs, and Diagnostic Tests), By Application (Therapeutics, and Diagnostics), By Disease (Inflammatory Diseases, Endocrine & Metabolic Disorders, Infectious Diseases, Cancer, and Others), By Technology (Proteomics, Genomics, and Metabolomics) and By Region

Key Findings

  • Human Microbiome Market is estimated to grow at a CAGR of 22.67% over the forecast period 2020-2026.
  • The products of global human microbiome market are segmented into prebiotics, probiotics, medical foods, foods, drugs, and diagnostic tests.
  • Therapeutics segment accounted for larger share among the applications of human microbiome.
  • Among the diseases, infectious diseases are expected to grow at rapid pace during the forecast period 2020 to 2026.
  • On basis of technology, the genomics segment is expected to grow at faster rate during the forecast period 2020-2026.
  • North America region is the major revenue contributor for global human microbiome market.

Increasing demand for development of human microbiome therapy, global growth of geriatric population, and increasing incidence of lifestyle-related diseases are driving the human microbiome market. Factors such as increasing number of collaborations between key players, advancements in human microbiome technologies, and customer awareness regarding personalized nutrition are imparting growth opportunities for overall human microbiome market share.

Lack of enhanced research and development activities and stringent government regulations are restraining the human microbiome market size. Therapeutics application accounted for a larger share owing to increasing R&D investments, and technological advancements. Companies are engaged in developing their own technology platforms and number of organizations developing numerous products related to human microbiome is boosting the market growth.

Based on diseases, the human microbiome market is segmented into five types such as inflammatory diseases, endocrine & metabolic disorders, infectious diseases, cancer, and others. Among these, the infectious diseases are expected to grow at faster rates due to rising incidence of various infections, increasing R&D investments into targeted anti-microbial products, and increasing clinical trials.

Genomics technology is the fastest-growing segment owing to increase in number of projects funded by private and government organizations, and declining price of next-generation sequencing. Globally, North America is the major contributor due to rising investments by government organizations to support microbiome research, increasing incidence of lifestyle diseases such as obesity, cardiovascular diseases, and others, and growing consumption of probiotic products.

Global Human Microbiome Market Insights

Major trends shaping the near and long term future of the industry, opportunities, drivers and restraints of Human Microbiome market, detailed porter’s five forces analysis and competitive insights are included in the research report.

Global Human Microbiome Market Share by Product

The report presents the detailed annual outlook of each product of the Human Microbiome market to 2026. The report studied 6 products including Prebiotics, Probiotics, Medical Foods, Foods, Drugs, and Diagnostic Tests.

Global Human Microbiome Market Size by Application

The report presents in-depth insights into each of the leading Human Microbiome applications along with annual forecasts to 2026. Various applications that are studied in the report include Therapeutics, and Diagnostics. Among these, therapeutics application accounted for larger share.

Global Human Microbiome Market Size by Disease

The report presents in-depth insights into each of the leading Human Microbiome diseases along with annual forecasts to 2026. Various diseases that are studied in the report include Inflammatory Diseases, Endocrine & Metabolic Disorders, Infectious Diseases, Cancer, and Others. Of these, infectious diseases expected to grow at faster rate during the forecast period 2020 to 2026.

Global Human Microbiome Market Share by Technology

The report presents detailed annual outlook of each technology of the Human Microbiome market to 2026. The report categorized into 3 technologies including Proteomics, Genomics, and Metabolomics. Based on technology, the genomics is fastest growing segment during the forecast period 2020-2026.

Global Human Microbiome Market Revenue by Region

The current Human Microbiome market size in terms of revenue across 5 regions including North America, Europe, Asia Pacific, South & Central America and Middle East & Africa are studied in the report. In addition, historic data from 2018 and annual forecasts to 2026 are also included in the research report. North America is the major revenue contributor for Global Human Microbiome Market.

Global Human Microbiome Market Analysis by Company

Top 10 leading companies in global Human Microbiome market are analyzed in the report along with their business overview, operations, geographical locations, financial analysis, SWOT profile and Human Microbiome products & services.

Global Human Microbiome Market News and Recent Developments

Latest news and industry developments in terms of Human Microbiome capacity expansions, acquisitions, organic & inorganic growth strategies, joint ventures and collaborations, product launches, market expansions etc are included in the report.

Scope of the Global Human Microbiome Market Report Includes

Long term perspective on the Global Human Microbiome industry: 2019 (base year), 2020- 2026 (forecast period)

Global Human Microbiome Market- Forecasts by Segments – Product, Application, Disease, and Technology by Region.

  1. The report provides the market outlook by 6 products including Prebiotics, Probiotics, Medical Foods, Foods, Drugs, and Diagnostic Tests.
  2. The report categorizes the market based on application into 2 categories including Therapeutics, and Diagnostics.
  3. The report categorizes the global Human Microbiome market based on disease into 5 categories including Inflammatory Diseases, Endocrine & Metabolic Disorders, Infectious Diseases, Cancer, and Others.
  4. The research work categorizes the Global Human Microbiome Market based on technologies into 3 categories including Proteomics, Genomics, and Metabolomics.
  5. Global Human Microbiome Market across 5 regions including Asia Pacific, North America, South and Central America, Europe, and Middle East and Africa are covered.

Global Human Microbiome Market- Strategic Analysis Review

1. Key strategies opted by leading players

2. Short to Long Term Industry Trends

3. Porter’s Five Forces Analysis

4. Supply side and Demand Side Drivers and Challenges

Global Human Microbiome Market- Growth Opportunities

1. Potential New Business Opportunities

2. Key Areas of Focus in forecast period

Global Human Microbiome Market- Competitive Scenario

1. 10 companies are analyzed in the report including DowDuPont Inc., Enterome Bioscience, Ubiome, Inc., Seres Therapeutics, 4D Pharma PLC, Second Genome, Synlogic, Ferring Pharmaceuticals, Vedanta Biosciences, Inc., and Evelo Biosciences, Inc.

2. Company Peer-to-Peer Comparison

3. Company Profile and SWOT Analysis

4. Financial Analysis

1 of 3

Table of Contents:



1. Table of Contents
1.1 List of Tables
1.2 List of Figures



2. Introduction to Global Human Microbiome Market
2.1 Global Human Microbiome Market Snapshot, 2019
2.2 Human Microbiome Industry Overview
2.3 Research Perspective



3. Global Human Microbiome Market- Strategic Analysis 
3.1 Short Term and Long Term Industry Trends Affecting Global Human Microbiome Market
3.2 Leading Human Microbiome Types Targeted by Global Manufacturers 
3.3 Key Consumption Patterns of Human Microbiome
3.4 Potential Markets Vital for business Expansion 
3.5 Five Forces Analysis
3.6 Drivers and Restraints



4. Global Human Microbiome Market Outlook and Growth Opportunities by Product
4.1 Human Microbiome Demand by Prebiotics, Market Outlook, 2020- 2026
4.2 Human Microbiome Demand by Probiotics, Market Outlook, 2020- 2026
4.3 Human Microbiome Demand by Medical Foods, Market Outlook, 2020- 2026
4.4 Human Microbiome Demand by Foods, Market Outlook, 2020- 2026
4.5 Human Microbiome Demand by Drugs, Market Outlook, 2020- 2026
4.6 Human Microbiome Demand by Diagnostic Tests, Market Outlook, 2020- 2026



5. Global Human Microbiome Market Outlook and Growth Opportunities by Application
5.1 Human Microbiome Demand by Therapeutics, Market Outlook, 2020- 2026
5.2 Human Microbiome Demand by Diagnostics, Market Outlook, 2020- 2026



6. Global Human Microbiome Market Outlook and Growth Opportunities by Disease 
6.1 Human Microbiome Demand by Inflammatory Diseases, Market Outlook, 2020- 2026
6.2 Human Microbiome Demand by Endocrine & Metabolic Disorders, Market Outlook, 2020- 2026
6.3 Human Microbiome Demand by Infectious Diseases, Market Outlook, 2020- 2026
6.4 Human Microbiome Demand by Cancer, Market Outlook, 2020- 2026
6.5 Human Microbiome Demand by Other diseases, Market Outlook, 2020- 2026



7. Global Human Microbiome Market Outlook and Growth Opportunities by Technology
7.1 Human Microbiome Demand by Proteomics, Market Outlook, 2020- 2026
7.2 Human Microbiome Demand by Genomics, Market Outlook, 2020- 2026
7.3 Human Microbiome Demand by Metabolomics, Market Outlook, 2020- 2026



8. Asia Pacific Human Microbiome Market Outlook and Growth Opportunities
8.1 Key Findings, 2019
8.2 Asia Pacific Human Microbiome Market Outlook by Product, 2020- 2026
8.3 Asia Pacific Human Microbiome Market Outlook by Application, 2020- 2026
8.4 Asia Pacific Human Microbiome Market Outlook by Disease, 2020- 2026
8.5 Asia Pacific Human Microbiome Market Outlook by Technology, 2020- 2026
8.6 Asia Pacific Human Microbiome Market Outlook by Country, 2020- 2026



9. Europe Human Microbiome Market Outlook and Growth Opportunities
9.1 Key Findings, 2019
9.2 Europe Human Microbiome Market Outlook by Product, 2020- 2026
9.3 Europe Human Microbiome Market Outlook by Application, 2020- 2026
9.4 Europe Human Microbiome Market Outlook by Disease, 2020- 2026
9.5 Europe Human Microbiome Market Outlook by Technology, 2020- 2026
9.6 Europe Human Microbiome Market Outlook by Country, 2020- 2026



10. North America Human Microbiome Market Outlook and Growth Opportunities
10.1 Key Findings, 2019
10.2 North America Human Microbiome Market Outlook by Product, 2020- 2026
10.3 North America Human Microbiome Market Outlook by Application, 2020- 2026
10.4 North America Human Microbiome Market Outlook by Disease, 2020- 2026
10.5 North America Human Microbiome Market Outlook by Technology, 2020- 2026
10.6 North America Human Microbiome Market Outlook by Country, 2020- 2026



11. South & Central America Human Microbiome Market Outlook and Growth Opportunities
11.1 Key Findings, 2019
11.2 South & Central America Human Microbiome Market Outlook by Product, 2020-2026
11.3 South & Central America Human Microbiome Market Outlook by Application, 2020- 2026
11.4 South & Central America Human Microbiome Market Outlook by Disease, 2020- 2026
11.5 South & Central America Human Microbiome Market Outlook by Technology, 2020- 2026
11.6 South & Central America Human Microbiome Market Outlook by Country, 2020- 2026



12. Middle East & Africa Human Microbiome Market Outlook and Growth Opportunities
12.1 Key Findings, 2019
12.2 Middle East & Africa Human Microbiome Market Outlook by Product, 2020- 2026
12.3 Middle East & Africa Human Microbiome Market Outlook by Application, 2020- 2026
12.4 Middle East & Africa Human Microbiome Market Outlook by Disease, 2020- 2026
12.5 Middle East & Africa Human Microbiome Market Outlook by Technology, 2020- 2026
12.6 Middle East & Africa Human Microbiome Market Outlook by Country, 2020- 2026



13. Competitive Landscape
13.1 Leading Players (Company Profile, SWOT Analysis, Human Microbiome products, Financial Analysis)
13.1.1 DowDuPont Inc. 
13.1.2 Enterome Bioscience
13.1.3 Ubiome, Inc.  
13.1.4 Seres Therapeutics
13.1.5 4D Pharma PLC  
13.1.6 Second Genome
13.1.7 Synlogic
13.1.8 Ferring Pharmaceuticals
13.1.9 Vedanta Biosciences, Inc.
13.1.10 Evelo Biosciences, Inc.
13.2 Company Benchmarking 
13.3 Financial Analysis



14. Recent News and Deals Landscape
14.1 Mergers and Acquisitions
14.2 New Disease Launches
14.3 Asset Transactions
14.4 Financial Announcements



15. Appendix
15.1 OG Analysis Expertise
15.2 Sources and Research Applicationology
15.3 Contact Information

 



1 of 3

Type Delivery Format Details
Hard Copy A printed copy of the report will be shipped to you.
CD-ROM The report will be shipped to you in CD ROM format.
SINGLE USER Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows one specific user access to the product.
SITE LICENSE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all users within a given geographical location of your organization access to the product.
ENTERPRISEWIDE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all employees within your organization in different geographic locations access to the product.
1 - 5 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to five users have access to the product.
1 – 10 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to ten users have access to the product.
1 – 15 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to fifteen users have access to the product.
1 - 5 USERS Online Access (For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to five users have access to the product.
1 - 10 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to ten users have access to the product.
1 - 15 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to fifteen users have access to the product.
1 - 5 USERS Electronic (Excel) The Excel spreadsheet will be emailed to you. The license allows up to five users have access to the product.


PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.